Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Alignment Healthcare, Inc. (NASDAQ: ALHC) is a Medicare Advantage-focused health insurer whose news flow centers on senior care, membership growth and quality performance. Through its Alignment Health and Alignment Health Plan brands, the company regularly issues updates on Medicare Advantage plan offerings, CMS Star Ratings, membership trends and financial results, giving investors and policy observers insight into its position within the Medicare Advantage market.
News about ALHC often highlights membership growth and market expansion. For example, the company has reported health plan membership in the hundreds of thousands and described compounded annual membership growth since its IPO. It also publishes guidance ranges for future membership and adjusted EBITDA, along with non-GAAP reconciliations that explain measures such as adjusted gross profit and adjusted EBITDA.
Another major news theme is quality and recognition. Alignment frequently reports its CMS Star Ratings, noting that 100% of its members are in plans rated 4 stars or higher for consecutive years, and details performance in key states such as California, Nevada, North Carolina and Texas. Press releases also cover external recognition, including U.S. News & World Report naming Alignment Health Plan a Best Insurance Company for Medicare Advantage across all five states where it operates.
Readers following ALHC news will also see announcements about new and enhanced Medicare Advantage products, special needs plans, and partnerships with provider organizations like Intermountain Health and Suvida Healthcare. These items describe new co-branded plans, bilingual care initiatives and benefit designs aimed at addressing issues such as food insecurity and transportation barriers for seniors.
In addition, Alignment issues earnings releases and conference call notices, including quarterly revenue, membership metrics, non-GAAP financial measures and outlook commentary. For ongoing coverage of these developments, investors and researchers can use this news page to review historical and recent press releases related to ALHC.
Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the upcoming William Blair 45th Annual Growth Stock Conference. The company's presentation is scheduled for Wednesday, June 4, at 2 p.m. CDT. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.
The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.
Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has announced two key leadership appointments to enhance its AI-enabled Medicare Advantage platform. Dr. Arta Bakshandeh has been named President of AVA®, the company's proprietary platform that utilizes 200+ data sources and 13,000+ attributes for personalized healthcare insights. Aly Duzich has been promoted to Chief Experience Officer to optimize member experience.
AVA platform leverages trusted AI to improve senior health outcomes and quality of care while reducing costs. The company has grown to over 200,000 health plan members since its IPO in March 2021. Both appointments aim to strengthen Alignment's care management and service delivery approach, integrating technology with compassionate care for seniors.
Alignment Healthcare (NASDAQ: ALHC) has scheduled the release of its first quarter 2025 financial results for Thursday, May 1, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.
Investors and interested parties can access a live audio webcast of the conference call through the company's investor relations website at https://ir.alignmenthealth.com/. The webcast replay will be available for approximately 12 months after the call.
Sutter Health and Alignment Healthcare (NASDAQ: ALHC) have renewed their strategic partnership, ensuring continued in-network access to Sutter's healthcare network for Alignment's Medicare Advantage members in Northern California. The agreement covers members enrolled in Sutter Advantage HMO and My Choice PPO health plans across 10 counties.
Sutter Health plans to expand its healthcare infrastructure starting in 2025, including:
- 27 new ambulatory care sites
- 27 urgent care centers
- 22 ambulatory surgery centers
The collaboration combines Sutter Health's provider network with Alignment's care model and AVA® technology platform, focusing on serving high-risk individuals with chronic conditions. The partnership spans across Placer, Sacramento, San Francisco, San Joaquin, San Mateo, Santa Clara, Santa Cruz, Sonoma, Stanislaus, and Yolo counties.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation in two major healthcare conferences in March 2025. The company will present at the Leerink Global Healthcare Conference on Tuesday, March 11, at 3:40 p.m. EDT, followed by a presentation at the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, at 10:30 a.m. EDT.
Both presentations will be accessible via webcast, with replays available on Alignment's investor relations website at ir.alignmenthealth.com.
Alignment Healthcare (ALHC) reported strong growth in its Q4 and full-year 2024 results. Health plan membership reached 189,100 as of December 31, 2024, marking a 58.6% increase year-over-year. The company achieved its first full year of positive adjusted EBITDA as a public company.
Q4 2024 highlights include total revenue of $701.2 million, up 50.7% year-over-year, with a medical benefits ratio of 87.5%. The company recorded an adjusted EBITDA of $1.4 million, despite a net loss of $(31.1) million.
For full-year 2024, total revenue reached $2,703.6 million, increasing 48.3% year-over-year, with an adjusted EBITDA of $1.3 million and a net loss of $(128.1) million. Looking ahead, ALHC provided 2025 revenue guidance of $3.72-3.78 billion, projecting 37.6-39.6% growth, with adjusted EBITDA expected between $35-60 million.